These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10624597)

  • 21. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B.
    Vutien P; Trinh HN; Nguyen K; Garcia RT; Nguyen HA; Levitt BS; Nguyen L; Ha NB; Ahmed A; Daugherty T; Garcia G; Nguyen MH
    Aliment Pharmacol Ther; 2013 Feb; 37(4):464-72. PubMed ID: 23278246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
    Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
    J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Med Virol; 2004 Oct; 74(2):237-45. PubMed ID: 15332272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
    Cho SW; Hahm KB; Kim JH
    Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis.
    Sato S; Suzuki K; Akahane Y; Akamatsu K; Akiyama K; Yunomura K; Tsuda F; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    Ann Intern Med; 1995 Feb; 122(4):241-8. PubMed ID: 7825758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of the 1896 precore mutation in patients and blood donors with hepatitis B virus infection from the Indian subcontinent.
    Vivekanandan P; Abraham P; Sridharan G; Chandy G; Shaji RV; Daniel D; Raghuraman S; Daniel HD; Subramaniam T
    Mol Diagn; 2004; 8(1):51-6. PubMed ID: 15230642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of precore mutants of hepatitis B in the United Kingdom.
    Ballard AL; Boxall EH
    J Med Virol; 2000 Dec; 62(4):463-70. PubMed ID: 11074475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.
    Nagasaka A; Hige S; Marutani M; Tsunematsu I; Saito M; Yamamoto Y; Konishi S; Asaka M
    Dig Dis Sci; 1998 Nov; 43(11):2473-8. PubMed ID: 9824137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
    Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
    Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion.
    Karasawa T; Aizawa Y; Zeniya M; Kuramoto A; Shirasawa T; Toda G
    J Med Virol; 1995 Apr; 45(4):373-80. PubMed ID: 7666040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
    Zampino R; Marrone A; Finnström N; Eriksson T; Törmänen V; Hedrum A; Attanasio V; Rosario P; Utili R; Ruggiero G
    Infez Med; 2005 Jun; 13(2):86-96. PubMed ID: 16220028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core promoter and precore mutants of hepatitis B virus: prevalence and clinical relevance in chronic hepatitis patients.
    Tangkijvanich P; Theamboonlers A; Jantaradsamee P; Hirsch P; Mahachai V; Suwangool P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):627-35. PubMed ID: 11414402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of core promotor and precore mutants of hepatitis B virus in thailand by RFLP and sequencing.
    Theamboonlers A; Tangkijvanich P; Jantaradsamee P; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):750-5. PubMed ID: 10928370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.